comparemela.com

Latest Breaking News On - Care covid - Page 13 : comparemela.com

Anti-Vaxxers beware: Covid cases rising in Los Angeles County, Unvaccinated people in trouble

Anti-Vaxxers beware: Covid cases rising in Los Angeles County, Unvaccinated people in trouble
ibtimes.co.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibtimes.co.in Daily Mail and Mail on Sunday newspapers.

Covid update: Delhi wins, Kerala loses coronavirus battle, TPR still above 10

Covid update: Delhi wins, Kerala loses coronavirus battle, TPR still above 10
ibtimes.co.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibtimes.co.in Daily Mail and Mail on Sunday newspapers.

Covid third wave in India: Alarming coronavirus figures from Kerala shed clues [details]

Covid third wave in India: Alarming coronavirus figures from Kerala shed clues [details]
ibtimes.co.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibtimes.co.in Daily Mail and Mail on Sunday newspapers.

Investigative Drug GC376 shows potential as post-infection COVID-19 treatment option: Study

Are Covid vaccines safe for pregnant women While vaccination may potentially help in preventing the contraction of COVID-19, ideal treatment post-infection has remained evasive. An important aspect of the infecting mechanism of the SARS-CoV-2 virus is its replication cycle, whose decrease can help tackle the disease effectively. Now, a new study has found that an experimental broad-spectrum antiviral medication known as GC376 may serve as an ideal postinfection treatment for the novel coronavirus infection. According to the multi-institutional study, animal models that were infected with the SARS-CoV-2 virus and treated with modified form (deuterated) GC376 significantly improved survival and reduced viral load. The study was published in the journal

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.